UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going

Experimental & molecular medicine, 2017-12, Vol.49 (12), p.e406-e406

2017

Volltextzugriff (PDF)

PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells

Cancer research (Chicago, Ill.), 2019-01, Vol.79 (1), p.133-145

2019

Volltextzugriff (PDF)

Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy

Frontiers in endocrinology (Lausanne), 2021-05, Vol.12, p.679000-679000

2021

Volltextzugriff (PDF)

MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer

Cancer research (Chicago, Ill.), 2021-10, Vol.81 (19), p.4964-4980

2021

Volltextzugriff (PDF)

FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer

Clinical cancer research, 2016-08, Vol.22 (15), p.3950-3960

2016

Volltextzugriff (PDF)

Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis

Frontiers in endocrinology (Lausanne), 2021-06, Vol.12, p.691557-691557

2021

Volltextzugriff (PDF)

Recent progress of experimental model in pancreatic neuroendocrine tumors: drawbacks and challenges

Endocrine, 2023-05, Vol.80 (2), p.266-282

2023

Volltextzugriff (PDF)

Cancer immunometabolism: advent, challenges, and perspective

Molecular cancer, 2024-04, Vol.23 (1), p.72-72, Article 72

2024

Volltextzugriff (PDF)

Completely 3-dimensional laparoscopic pancreaticoduodenectomy with modified Blumgart pancreaticojejunostomy: an analysis of 100 consecutive cases

Langenbeck's archives of surgery, 2023-03, Vol.408 (1), p.126-126, Article 126

2023

Volltextzugriff (PDF)

Establishment and characterization of the third non-functional human pancreatic neuroendocrine tumor cell line

Human cell : official journal of Human Cell Research Society, 2022-07, Vol.35 (4), p.1248-1261

2022

Volltextzugriff (PDF)

Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor

Human cell : official journal of Human Cell Research Society, 2024-09, Vol.37 (5), p.1522-1534

2024

Volltextzugriff (PDF)

Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment

Cancer biology & medicine, 2023-09, Vol.20 (10), p.1-7

2023

Volltextzugriff (PDF)

Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway

Frontiers in oncology, 2022-01, Vol.12, p.822039-822039

2022

Volltextzugriff (PDF)

The Interplay of Four Main Pathways Recomposes Immune Landscape in Primary and Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Frontiers in oncology, 2022-05, Vol.12, p.808448-808448

2022

Volltextzugriff (PDF)

MEN1 Deficiency‐Driven Activation of the β‐Catenin‐MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance

Advanced science, 2024-09, Vol.11 (35), p.e2308417-n/a

2024

Volltextzugriff (PDF)

Minimally invasive enucleation of pancreatic tumors: The main pancreatic duct is no longer a restricted area

Heliyon, 2023-11, Vol.9 (11), p.e21917-e21917, Article e21917

2023

Volltextzugriff (PDF)

Papillary-like main pancreatic duct invaginated pancreaticojejunostomy versus duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: A prospective randomized trial

Surgery, 2015-11, Vol.158 (5), p.1211-1218

2015

Volltextzugriff (PDF)

Organoid model: A new hope for pancreatic cancer treatment?

Biochimica et biophysica acta. Reviews on cancer, 2021-01, Vol.1875 (1), p.188466-188466, Article 188466

2021

Volltextzugriff (PDF)

Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors

Biochimica et biophysica acta. Reviews on cancer, 2022-09, Vol.1877 (5), p.188782-188782, Article 188782

2022

Volltextzugriff (PDF)

Unraveling the mysteries of MGMT: Implications for neuroendocrine tumors

Biochimica et biophysica acta. Reviews on cancer, 2024-11, Vol.1879 (6), p.189184, Article 189184

2024

Volltextzugriff (PDF)

Role of angiogenesis in pancreatic cancer biology and therapy

Biomedicine & pharmacotherapy, 2018-12, Vol.108, p.1135-1140

2018

Volltextzugriff (PDF)

Ferroptosis: Final destination for cancer?

Cell proliferation, 2020-03, Vol.53 (3), p.e12761-n/a

2020

Volltextzugriff (PDF)

Laparoscopic Duodenum and Spleen-Preserving Subtotal or Total Pancreatectomy: A Parenchyma-Sparing Strategy for Main Duct Intraductal Papillary Mucinous Neoplasms (with Video)

Annals of surgical oncology, 2024-09

2024

Volltextzugriff (PDF)

YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer

Cancer letters, 2024-10, Vol.602, p.217197, Article 217197

2024

Volltextzugriff (PDF)

MEN1 Degradation Induced by Neddylation and the CUL4B-DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression

Cancer research (Chicago, Ill.), 2023-07, Vol.83 (13), p.2226-2247

2023

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

KollektionOxford journals

ThemaPancreatic Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going

PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells

Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy

MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer

FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer

Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis

Recent progress of experimental model in pancreatic neuroendocrine tumors: drawbacks and challenges

Cancer immunometabolism: advent, challenges, and perspective

Completely 3-dimensional laparoscopic pancreaticoduodenectomy with modified Blumgart pancreaticojejunostomy: an analysis of 100 consecutive cases

Establishment and characterization of the third non-functional human pancreatic neuroendocrine tumor cell line

Comparison among different preclinical models derived from the same patient with a non-functional pancreatic neuroendocrine tumor

Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment

Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway

The Interplay of Four Main Pathways Recomposes Immune Landscape in Primary and Metastatic Gastroenteropancreatic Neuroendocrine Tumors

MEN1 Deficiency‐Driven Activation of the β‐Catenin‐MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance

Minimally invasive enucleation of pancreatic tumors: The main pancreatic duct is no longer a restricted area

Papillary-like main pancreatic duct invaginated pancreaticojejunostomy versus duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: A prospective randomized trial

Organoid model: A new hope for pancreatic cancer treatment?

Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors

Unraveling the mysteries of MGMT: Implications for neuroendocrine tumors

Role of angiogenesis in pancreatic cancer biology and therapy

Ferroptosis: Final destination for cancer?

Laparoscopic Duodenum and Spleen-Preserving Subtotal or Total Pancreatectomy: A Parenchyma-Sparing Strategy for Main Duct Intraductal Papillary Mucinous Neoplasms (with Video)

YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer

MEN1 Degradation Induced by Neddylation and the CUL4B-DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression

Aktive Filter

Suchergebnisse filtern